Work

A phase II study of the anti-CTLA4 monoclonal antibody (mAb), CP-675,206, in patients with refractory metastatic adenocarcinoma of the colon or rectum

Year: 2007

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2007.25.18_suppl.3035

Authors: K. Y. Chung, I. Gore, L. Fong, A. Venook, P. Dorazio, D. Healey, D. Pavlov, L. B. Saltz

Institutions: Memorial Sloan Kettering Cancer Center, University of California, San Francisco, Pfizer (United States)

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2226966159

Cites:

Cited by: 6

Related to: 10